Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

ADMA Biologics Inc (ADMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

ADMA Biologics Inc (ADMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

ADMA Biologics Inc (ADMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

ADMA Biologics Inc (ADMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

ADMA Biologics Inc (ADMA Biologics) is an integrated biopharmaceutical and specialty immunoglobulin company that develops, produces, and commercializes specialty biologics to treat immune deficiencies and prevent certain infectious diseases. The company develops RI-002, is a specialty plasma-derived, polyclonal, intravenous immune globulin, derived from human plasma containing naturally occurring polyclonal antibodies to treat Primary Immune Deficiency Disease. ADMA Biologics' target treatment areas include bacterial infections, respiratory syncytial virus and primary immune deficiency diseases. It also operates bio centers which carry out plasma collection and offer blood plasma to manufacture the company's products. ADMA Biologics is headquartered in Ramsey, New Jersey, the US.

ADMA Biologics Inc (ADMA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ADMA Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

ADMA Biologics Acquires Certain Assets from Biotest Pharma 11

Venture Financing 13

ADMA Biologics Secures USD20 Million from Oxford Finance 13

Adma Biologics Secures USD5 Million from Hercules 14

ADMA Biologics Secures Venture Funding from Biomark Capital 16

ADMA Plasma Biologics Raises USD 17.6 Million In Venture Financing 17

Licensing Agreements 18

Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 18

Adma Biologics Amends Licensing Agreement With Biotest For IGIV 19

Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 20

Equity Offering 21

ADMA Biologics Raises USD40 Million in Public Offering of Shares 21

ADMA Biologics to Raise Funds through Public Offering of Shares 23

ADMA Biologics Raises USD42 Million in Public Offering of Shares 24

ADMA Biologics Plans to Raise Funds through Secondary Offering of Shares 26

ADMA Biologics Raises USD14 Million in Public Offering of Shares 28

ADMA Biologics Raises USD11.2 Million in Public Offering of Shares 30

ADMA Biologics Completes IPO For USD 28.5 Million 32

ADMA Biologics Raises USD17.6 Million in Private Placement of Shares 33

Acquisition 35

R&R Acquisition Acquires ADMA Biologics In Reverse Acquisition 35

ADMA Biologics Inc-Key Competitors 36

ADMA Biologics Inc-Key Employees 37

ADMA Biologics Inc-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 39

Financial Announcements 39

Aug 10, 2018: ADMA Biologics reports second quarter 2018 financial results 39

May 14, 2018: ADMA Biologics Reports First Quarter 2018 Financial Results 41

Mar 05, 2018: ADMA Biologics Announces Full Year 2017 Financial Results 42

Nov 03, 2017: ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results 43

Aug 11, 2017: ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results 45

May 12, 2017: ADMA Biologics Provides Corporate Update and Reports First Quarter 2017 Financial Results 47

Feb 24, 2017: ADMA Biologics Reports Year End 2016 Financial Results, Accomplishments and Upcoming Milestones 48

Legal and Regulatory 49

Jul 26, 2018: Adma Biologics reports successful close-out of its April 2018 FDA compliance inspection 49

Other Significant Developments 50

Jun 27, 2017: ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders 50

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

List of Tables

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ADMA Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ADMA Biologics Inc, Deals By Therapy Area, 2012 to YTD 2018 9

ADMA Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

ADMA Biologics Acquires Certain Assets from Biotest Pharma 11

ADMA Biologics Secures USD20 Million from Oxford Finance 13

Adma Biologics Secures USD5 Million from Hercules 14

ADMA Biologics Secures Venture Funding from Biomark Capital 16

ADMA Plasma Biologics Raises USD 17.6 Million In Venture Financing 17

Adma Biologics Enters Into Licensing Agreement With Biotest Pharma For RSV Immune Globulin 18

Adma Biologics Amends Licensing Agreement With Biotest For IGIV 19

Adma Biologics Enters Into Licensing Agreement With Biotest For Varicella Zoster Immune Globulin 20

ADMA Biologics Raises USD40 Million in Public Offering of Shares 21

ADMA Biologics to Raise Funds through Public Offering of Shares 23

ADMA Biologics Raises USD42 Million in Public Offering of Shares 24

ADMA Biologics Plans to Raise Funds through Secondary Offering of Shares 26

ADMA Biologics Raises USD14 Million in Public Offering of Shares 28

ADMA Biologics Raises USD11.2 Million in Public Offering of Shares 30

ADMA Biologics Completes IPO For USD 28.5 Million 32

ADMA Biologics Raises USD17.6 Million in Private Placement of Shares 33

R&R Acquisition Acquires ADMA Biologics In Reverse Acquisition 35

ADMA Biologics Inc, Key Competitors 36

ADMA Biologics Inc, Key Employees 37

ADMA Biologics Inc, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

ADMA Biologics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person